SUNPHARMA

Sun Pharmaceutical Industries Share Price Sun Pharmaceutical Industries

₹1,620.55
16.4 (1.02%)
  • Advice
  • Hold
29 March, 2024 19:05 BSE: 524715 NSE: SUNPHARMAISIN: INE044A01036

Start SIP in Sun Pharmaceutical Industries

Start SIP

Sun Pharmaceutical Industries Performance

Day Range

  • Low 1,608
  • High 1,634
₹ 1,620

52 Week Range

  • Low 922
  • High 1,634
₹ 1,620
  • Open Price1,610
  • Previous Close1,604
  • Volume4427587

Sun Pharmaceutical Industries Share Price

  • Over 1 Month 2.97%
  • Over 3 Month 28.4%
  • Over 6 Month 43.12%
  • Over 1 Year 64.66%

Sun Pharmaceutical Industries Key Statistics

P/E Ratio 43.7
PEG Ratio 0.4
Market Cap Cr 388,824
Price to Book Ratio 6.6
EPS 14
Dividend 0.8
Relative Strength Index 65.12
Money Flow Index 52.9
MACD Signal 24.42
Average True Range 33.04
Sun Pharmaceutical Industries Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 4,9045,0964,3835,801
Operating Expenses Qtr Cr 3,7153,7103,5173,588
Operating Profit Qtr Cr 1,3591,3869492,361
Depreciation Qtr Cr 400393415412
Interest Qtr Cr 215194158161
Tax Qtr Cr 30189-9
Net Profit Qtr Cr 721889381-1,021
IndicatorMar 2023
Total Revenue Annual Cr 21,091
Operating Expenses Annual Cr 14,339
Operating Profit Annual in Cr 6,473
Depreciation Cr 1,601
Interest Annual Cr 472
Tax Annual Cr 50
Net Profit Annual Cr 1,691
IndicatorMar 2023
Cash from Operating Activity Annual Cr 507
Cash from Investing Activity Annual Cr -705
Cash from Financing Annual Activity Cr 169
Net Cash Flow Annual Cr -29
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 23,748
Fixed Assets Annual Cr 9,565
Total Non Current Assets Annual Cr 24,522
Total Current Assets Annual Cr 16,465
Total Assets Annual Cr 40,987
IndicatorMar 2023
Book Value Per Share Annual Rs 99
ROE Annual % 7
ROCE Annual % 16
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 32
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 12,15712,19211,78510,726
Operating Expenses Qtr Cr 8,9049,0138,6098,129
Operating Profit Qtr Cr 3,4773,1793,3322,802
Depreciation Qtr Cr 622633651672
Interest Qtr Cr 35498193
Tax Qtr Cr 432390468223
Net Profit Qtr Cr 2,5242,3762,0231,984
IndicatorMar 2023
Total Revenue Annual Cr 44,520
Operating Expenses Annual Cr 32,239
Operating Profit Annual in Cr 11,647
Depreciation Cr 2,529
Interest Annual Cr 172
Tax Annual Cr 848
Net Profit Annual Cr 8,474
IndicatorMar 2023
Cash from Operating Activity Annual Cr 4,959
Cash from Investing Activity Annual Cr -7,944
Cash from Financing Annual Activity Cr 2,376
Net Cash Flow Annual Cr -608
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 55,995
Fixed Assets Annual Cr 20,681
Total Non Current Assets Annual Cr 40,860
Total Current Assets Annual Cr 39,883
Total Assets Annual Cr 80,744
IndicatorMar 2023
Book Value Per Share Annual Rs 247
ROE Annual % 15
ROCE Annual % 16
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 28

Sun Pharmaceutical Industries Technicals

EMA & SMA

Current Price
₹1,620.55
16.4 (1.02%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹1,573.17
  • 50 Day
  • ₹1,506.79
  • 100 Day
  • ₹1,407.66
  • 200 Day
  • ₹1,284.58
  • 20 Day
  • ₹1,577.23
  • 50 Day
  • ₹1,510.34
  • 100 Day
  • ₹1,374.14
  • 200 Day
  • ₹1,238.46

Sun Pharmaceutical Industries Resistance and Support

PIVOT
₹1,620.84
Resistance
First Resistance 1,633.72
Second Resistance 1,646.88
Third Resistance 1,659.77
RSI 65.12
MFI 52.90
MACD Single Line 24.42
MACD 23.74
Support
First Resistance 1,607.67
Second Resistance 1,594.78
Third Resistance 1,581.62

Sun Pharmaceutical Industries Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 4,727,851 245,091,796 51.84
Week 4,424,965 276,029,286 62.38
1 Month 2,835,351 189,543,246 66.85
6 Month 2,271,242 140,521,759 61.87

Sun Pharmaceutical Industries Result Highlights

Sun Pharmaceutical Industries Synopsis

NSE-Medical-Generic Drugs

Sun Pharma. is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 20812.14 Cr. and Equity Capital is Rs. 239.93 Cr. for the Year ended 31/03/2023. Sun Pharmaceutical Industries Ltd. is a Public Limited Listed company incorporated on 01/03/1993 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1993PLC019050 and registration number is 019050.
Market Cap 388,824
Sales 20,584
Shares in Float 110.37
No of funds 1059
Yield 0.77
Book Value 16.37
U/D Vol ratio 1.9
LTDebt / Equity 32
Alpha 0.14
Beta 0.46

Sun Pharmaceutical Industries

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 54.48%54.48%54.48%54.48%
Mutual Funds 12.93%13.07%13.16%12.91%
Insurance Companies 5.02%5.06%5.12%5.12%
Foreign Portfolio Investors 17.08%16.78%16.48%16.88%
Financial Institutions/ Banks 0.04%0.06%0.08%0.03%
Individual Investors 5.41%5.55%5.65%5.7%
Others 5.04%5%5.03%4.88%

Sun Pharmaceutical Industries Management

Name Designation
Mr. Dilip S Shanghvi Managing Director
Mr. Sailesh T Desai Whole Time Director
Mr. Sudhir V Valia Non Exe.Non Ind.Director
Dr. Pawan Goenka Independent Director
Mr. Rama Bijapurkar Independent Director
Mr. Gautam Doshi Independent Director
Mr. Aalok D Shanghvi Whole Time Director
Mr. Sanjay Asher Independent Director
Mr. Rolf Hoffmann Independent Director

Sun Pharmaceutical Industries Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Sun Pharmaceutical Industries Corporate Action

Date Purpose Remarks
2024-01-31 Quarterly Results & Interim Dividend
2023-11-01 Quarterly Results
2023-08-03 Quarterly Results
2023-05-26 Audited Results & Final Dividend
2023-01-31 Quarterly Results & Interim Dividend
Date Purpose Remarks
2024-02-09 INTERIM Rs.8.50 per share(850%)Interim Dividend
2023-07-28 FINAL Rs.4.00 per share(400%)Final Dividend
2023-02-08 INTERIM Rs.7.50 per share(750%)Interim Dividend
2022-08-22 FINAL Rs.3.00 per share(300%)Final Dividend
2022-02-10 INTERIM Rs.7.00 per share(700%)Interim Dividend

Sun Pharmaceutical Industries MF Shareholding

Sun Pharmaceutical Industries FAQs

What is Share Price of Sun Pharmaceutical Industries ?

Sun Pharmaceutical Industries share price is ₹1,620 As on 29 March, 2024 | 18:51

What is the Market Cap of Sun Pharmaceutical Industries ?

The Market Cap of Sun Pharmaceutical Industries is ₹388824.2 Cr As on 29 March, 2024 | 18:51

What is the P/E ratio of Sun Pharmaceutical Industries ?

The P/E ratio of Sun Pharmaceutical Industries is 43.7 As on 29 March, 2024 | 18:51

What is the PB ratio of Sun Pharmaceutical Industries ?

The PB ratio of Sun Pharmaceutical Industries is 6.6 As on 29 March, 2024 | 18:51

What is the future of Sun Pharmaceutical Industries (Sun Pharma)?

Sun Pharmaceutical Industries (Sun Pharma) has an operating revenue of INR 36,704.43 Cr. on a trailing 12-month basis. Annual revenue growth of 3% is not great, Pre-tax margin of 8% is okay. Institutional holding has gone up in the last reported quarter is a positive sign. Analyst Recommendation on Sun Pharmaceutical Industries (Sun Pharma): HOLD

Who is the Managing Director of Sun Pharmaceutical Industries (Sun Pharma)?

Dilip Shanghvi is the Managing Director of Sun Pharmaceutical Industries (Sun Pharma).

What is the ROE of Sun Pharmaceutical Industries (Sun Pharma)?

The ROE of Sun Pharmaceutical Industries (Sun Pharma) is 6% which is fair but needs improvement.

Is Sun Pharmaceutical Industries (Sun Pharma) Debt to Equity Ratio?

Sun Pharmaceutical Industries (Sun Pharma) has a reasonable debt to equity of 2%, which signals a healthy balance sheet.

What is the PE ratio of Sun Pharmaceutical Industries (Sun Pharma)?

The PE ratio of Sun Pharmaceutical Industries (Sun Pharma) is 81.5.

Q2FY23